“…1,2 In particular, biaryl dimeric tetrahydroxanthones have gained signicant interest recently, not only because of their intriguing antibacterial and anticancer activities, but also owing to the synthetic challenges posed by their structures. Recent work from the groups of Bräse, [3][4][5][6][7]21,22 Nicolaou, 8 Tietze, [9][10][11]18,19 Porco, 12,[15][16][17] Kumamoto, 13 and Gao 14,20 et al has shown signicant progress in the synthesis of tetrahydroxanthone monomers [3][4][5][6][7][8][9][10][11][12][13][14] or homodimeric tetrahydroxanthones. [15][16][17][18][19][20][21][22] To the best of our knowledge, heterodimeric biaryl tetrahydroxanthones have rarely been synthesized, largely due to the synthetic challenges in assembling their sterically hindered biaryls.…”